| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.004 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.09 | 0.004 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.004 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.09 | 0.004 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |